Add time:07/19/2019         Source:sciencedirect.com

Background: Mitomycin-C (MMC) has been used for treating stricture. Topical MMC has been proven to inhibit fibroblasts proliferation and reduce the number of fibroblasts. Myofibroblasts are originally from fibroblasts. The scarring potential of myofibroblasts has been documented in many anatomical sites. The purpose of this study is to analyze the effect of topical MMC on myofibroblasts in healing anoplasty wounds in Wistar rats.

We also recommend Trading Suppliers and Manufacturers of mitomycin D (cas 10169-34-3). Pls Click Website Link as below: cas 10169-34-3 suppliers